Cargando…
3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds
BACKGROUND: Schistosomiasis is a disease caused by parasitic worms and more than 200 million people are infected worldwide. The emergence of resistance to the most commonly used drug, praziquantel (PZQ), makes the development of novel drugs an urgent task. 3-oxoacyl-ACP reductase (OAR), a key enzyme...
Autores principales: | Liu, Jian, Dyer, Dave, Wang, Jipeng, Wang, Shuqi, Du, Xiaofeng, Xu, Bin, Zhang, Haobing, Wang, Xiaoning, Hu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676400/ https://www.ncbi.nlm.nih.gov/pubmed/23762275 http://dx.doi.org/10.1371/journal.pone.0064984 |
Ejemplares similares
-
Aldose reductase from Schistosoma japonicum: crystallization and structure-based inhibitor screening for discovering antischistosomal lead compounds
por: Liu, Jian, et al.
Publicado: (2013) -
Insights into Acinetobacter baumannii fatty acid synthesis 3-oxoacyl-ACP reductases
por: Cross, Emily M., et al.
Publicado: (2021) -
A novel 3‐oxoacyl‐ACP reductase (FabG3) is involved in the xanthomonadin biosynthesis of Xanthomonas campestris pv. campestris
por: Yu, Yonghong, et al.
Publicado: (2019) -
Intake of Erythrocytes Required for Reproductive Development of Female Schistosoma japonicum
por: Wang, Jipeng, et al.
Publicado: (2015) -
Identification of Peptide Antagonists to Thioredoxin Glutathione Reductase of Schistosoma japonicum
por: Song, Li-Jun, et al.
Publicado: (2018)